Save information for later
Sign Up

Learn About Plasmacytoma

Who are the top Plasmacytoma Local Doctors?
Advanced in Plasmacytoma
Hematology Oncology
Advanced in Plasmacytoma
Hematology Oncology
2160 S First Ave, (luh - North Ent., Rm 7604), 
Maywood, IL 
 (19.2 mi)
Languages Spoken:
English, Hindi, Punjabi
Accepting New Patients

Sucha Nand is a Hematologist Oncology provider in Maywood, Illinois. Dr. Nand and is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Thalassemia, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Nand is currently accepting new patients.

Experienced in Plasmacytoma
Radiation Oncology
Experienced in Plasmacytoma
Radiation Oncology
1 Ingalls Dr, Cancer Care Center, 
Harvey, IL 
 (3.5 mi)
Languages Spoken:
English

Shankar Sanwalani is a Radiation Oncologist in Harvey, Illinois. Dr. Sanwalani and is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Progressive Osseous Heteroplasia.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Plasmacytoma
Hematology Oncology | Hematology | Oncology
Experienced in Plasmacytoma
Hematology Oncology | Hematology | Oncology

Primary Healthcare Associates Sc

71 W 156th St, 
Harvey, IL 
 (3.5 mi)
Languages Spoken:
English, Russian, Spanish
Accepting New Patients

Mark Kozloff is a Hematologist Oncology specialist and a Hematologist in Harvey, Illinois. Dr. Kozloff and is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Colorectal Cancer, Breast Cancer, Pancreatic Cancer, and Paget Disease of the Breast. Dr. Kozloff is currently accepting new patients.

What are the latest Plasmacytoma Clinical Trials?
Clinical Study of CD123 Targeting Chimeric Antigen Receptor NK Cells (CAR-NK) in the Treatment of Relapse/refractory Acute Myeloid Leukemia (AML)or Blastic Plasmacytoid Dendritic Cell Neoplasm(BPDCN)

Summary: This is a clincal trial initiated by investigator to evaluate the safety and efficacy of anti-CD123 CAR-NK in the treatment of patients with relapsed/refractory acute myeloid leukemia or blastic plasma cell like dendritic cell tumors.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Tissue Procurement For Hematolymphoid Conditions

Summary: RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center